Regulatory effects of bifidobacteria on the growth of other colonic bacteria - PubMed (original) (raw)
Regulatory effects of bifidobacteria on the growth of other colonic bacteria
G R Gibson et al. J Appl Bacteriol. 1994 Oct.
Abstract
In the human large intestine bifidobacteria are a numerically important group of micro-organisms which are considered to exert a range of biological activities related to host health. One aspect is the inhibitory effect of these bacteria on other species, possibly excluding long term colonization by invasive pathogens. It has been suggested that the mechanism of inhibition carried out by bifidobacteria is related to the fermentative production of acids such as acetate and lactate. Experiments reported in this paper attempted to address this theory. Co-culture experiments whereby Bifidobacterium infantis was incubated with Escherichia coli and Clostridium perfringens, in a variety of fermentation systems, indicated that the bifidobacterium was able to exert an inhibitory effect not necessarily related to acid production. Further studies showed that eight species of bifidobacteria could variously excrete an anti-microbial substance with a broad spectrum of activity. Species belonging to the genera Salmonella, Listeria, Campylobacter and Shigella, as well as Vibrio cholerae, were all affected. These results show that bifidobacteria are able to exert more than one mechanism of inhibition, which may be of some importance with regard to protection against gastroenteritis.
Similar articles
- Clostridial pathogenicity in experimental necrotising enterocolitis in gnotobiotic quails and protective role of bifidobacteria.
Butel MJ, Roland N, Hibert A, Popot F, Favre A, Tessedre AC, Bensaada M, Rimbault A, Szylit O. Butel MJ, et al. J Med Microbiol. 1998 May;47(5):391-9. doi: 10.1099/00222615-47-5-391. J Med Microbiol. 1998. PMID: 9879939 - Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine.
Wang X, Gibson GR. Wang X, et al. J Appl Bacteriol. 1993 Oct;75(4):373-80. doi: 10.1111/j.1365-2672.1993.tb02790.x. J Appl Bacteriol. 1993. PMID: 8226394 - NMR detection of 13CH313COOH from 3-13C-glucose: a signature for Bifidobacterium fermentation in the intestinal tract.
Wolin MJ, Zhang Y, Bank S, Yerry S, Miller TL. Wolin MJ, et al. J Nutr. 1998 Jan;128(1):91-6. doi: 10.1093/jn/128.1.91. J Nutr. 1998. PMID: 9430608 - Bacteriocin production by Bifidobacterium spp. A review.
Martinez FA, Balciunas EM, Converti A, Cotter PD, de Souza Oliveira RP. Martinez FA, et al. Biotechnol Adv. 2013 Jul-Aug;31(4):482-8. doi: 10.1016/j.biotechadv.2013.01.010. Epub 2013 Feb 4. Biotechnol Adv. 2013. PMID: 23384878 Review. - Antimicrobial proteinaceous compounds obtained from bifidobacteria: from production to their application.
Cheikhyoussef A, Pogori N, Chen W, Zhang H. Cheikhyoussef A, et al. Int J Food Microbiol. 2008 Jul 31;125(3):215-22. doi: 10.1016/j.ijfoodmicro.2008.03.012. Epub 2008 Apr 1. Int J Food Microbiol. 2008. PMID: 18514343 Review.
Cited by
- Role of nutraceuticals in human health.
Das L, Bhaumik E, Raychaudhuri U, Chakraborty R. Das L, et al. J Food Sci Technol. 2012 Apr;49(2):173-83. doi: 10.1007/s13197-011-0269-4. Epub 2011 Feb 26. J Food Sci Technol. 2012. PMID: 23572839 Free PMC article. - The Role of Mucosal Immunity and Recombinant Probiotics in SARS-CoV2 Vaccine Development.
Moradi-Kalbolandi S, Majidzadeh-A K, Abdolvahab MH, Jalili N, Farahmand L. Moradi-Kalbolandi S, et al. Probiotics Antimicrob Proteins. 2021 Oct;13(5):1239-1253. doi: 10.1007/s12602-021-09773-9. Epub 2021 Mar 26. Probiotics Antimicrob Proteins. 2021. PMID: 33770348 Free PMC article. Review. - Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity.
Liévin V, Peiffer I, Hudault S, Rochat F, Brassart D, Neeser JR, Servin AL. Liévin V, et al. Gut. 2000 Nov;47(5):646-52. doi: 10.1136/gut.47.5.646. Gut. 2000. PMID: 11034580 Free PMC article. - Bifidobacterium: Host-Microbiome Interaction and Mechanism of Action in Preventing Common Gut-Microbiota-Associated Complications in Preterm Infants: A Narrative Review.
Sadeghpour Heravi F, Hu H. Sadeghpour Heravi F, et al. Nutrients. 2023 Jan 30;15(3):709. doi: 10.3390/nu15030709. Nutrients. 2023. PMID: 36771414 Free PMC article. Review. - Human Milk Oligosaccharides: 2'-Fucosyllactose (2'-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula.
Vandenplas Y, Berger B, Carnielli VP, Ksiazyk J, Lagström H, Sanchez Luna M, Migacheva N, Mosselmans JM, Picaud JC, Possner M, Singhal A, Wabitsch M. Vandenplas Y, et al. Nutrients. 2018 Aug 24;10(9):1161. doi: 10.3390/nu10091161. Nutrients. 2018. PMID: 30149573 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources